Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer trials nationally

1

Recruiting in Illinois

2

Cities with sites

Cities in Illinois

Park Ridge 1Springfield 1

Recruiting trials in Illinois

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Park Ridge, Springfield

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.